Novel Adipose Tissue–Mediated Resistance to Diet-Induced Visceral Obesity in 11β-Hydroxysteroid Dehydrogenase Type 1–Deficient Mice

Morton, Nicholas M., Paterson, Janice M., Masuzaki, Hiroaki, Holmes, Megan C., Staels, Bart, Fievet, Catherine, Walker, Brian R., Flier, Jeffrey S. +2 more·2004·Diabetes
DOI 10.2337/diabetes.53.4.931

Cited by (547)

Items 401–500 of 547

  1. QSAR Study of Arylsulfonylpiperazine Inhibitors of 11β-HSD1 by GA-MLR, GA-PLS and GA-ANN
    Mehdi Nekoei, Nasser Goudarzi, Saeeid Nekoei, Majid Mohammadhosseini · 2014 · Analytical Chemistry Letters
  2. Is Your Metabolism Determined By (Cell) Fate?
    Brian J. Feldman · 2007 · Pediatric Research
  3. 11-Hydroxy-β-steroid dehydrogenase gene expression in canine adipose tissue and adipocytes: Stimulation by lipopolysaccharide and tumor necrosis factor α
    Vivien H. Ryan, Paul Trayhurn, Leif Hunter, Penelope Morris, Alexander J. German · 2011 · Domestic Animal Endocrinology
  4. Weight-Loss Drugs
    George A. Bray, Frank L. Greenway · 2007 · Humana Press eBooks
  5. Glycyrrhizic Acid as the Modulator of 11β -hydroxysteroid dehydrogenase (Type 1 and 2) in Rats under Different Physiological Conditions in Relation to the Metabolic Syndrome
    Hui Ping Yaw So Ha Ton · 2015 · Journal of Diabetes & Metabolism
  6. Regulation of 11β-hydroxysteroid dehydrogenase type 1 following caloric restriction and re-feeding is species dependent
    Christine Loerz, Claudia A. Staab-Weijnitz, Patricia Huebbe, Katrin Giller, Cornelia C. Metges, Gerald H Rimbach, Edmund Maser · 2017 · Chemico-Biological Interactions
  7. Glucocorticoid Metabolism and Activation
    Nantia Othonos, Jeremy Tomlinson · 2017 · Elsevier eBooks
  8. Sodium homeostasis is preserved in a global 11β‐hydroxysteroid dehydrogenase type 1 knockout mouse model
    Thorbjørn H. Christensen, Matthew A. Bailey, Christopher J. Kenyon, Boye Lagerbon Jensen, Robert W. Hunter · 2015 · Experimental Physiology
  9. Influence of hormones on osteogenic differentiation processes of mesenchymal stem cells
    Regina Ebert, Norbert Schütze, Tatjana Schilling, Lothar Seefried, Meike Weber, Ulrich Aran Nöth, J. Eulert, Franz Josef Jakob · 2006 · Expert Review of Endocrinology & Metabolism
  10. Obese Mouse Models
    Deborah J. Good · 2008 · Humana Press eBooks
  11. Pharmacokinetic characterization of 2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone, a novel 11β-hydroxysteroid dehydrogenase type 1 inhibitor in rats
    Zhi-Xia Zheng, Hyewon Seo, Hyun-Jung Kwak, K. Kim, J. Ahn, M. Bae, J. Song · 2016 · Archives of pharmacal research
  12. The Third International Symposium on Obesity and Hypertension ISOH'03: ‘Genetics and Molecular Mechanisms’ (October 23–25, 2003, Berlin Germany)
    Arya Mitra Sharma, Stefan Engeli, Friedrich Cameron Luft · 2005 · International Journal of Obesity
  13. Cell-type specific regulation of the human 11beta-hydroxysteroid dehydrogenase type 1 promoter
    Janin Andres, Knut Mai, Matthias Möhlig, Martin O. Weickert, Christiane Bumke‐Vogt, Sven Diederich, Andreas F. H. Pfeiffer, Volker Bähr, Joachim Spranger · 2007 · Archives of Physiology and Biochemistry
  14. Genetic independence of fat depots in cattle.
    A. R. Egarr · 2012 · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
  15. Molecular Pharmacology in Diabetes
    Flávio Reis, Rosa Fernandes · 2024 · International Journal of Molecular Sciences
  16. Tumor‑associated glucocorticoid inhibition by mifepristone reduces polymorphonuclear myeloid‑derived suppressor cells and promotes antitumor immunity in triple‑negative breast cancer‑bearing mice
    Masato Kobayashi, Chisana Konno, Ayato SHIMIZU, Masanori Kobayashi, Tatsuya HORI · 2026 · Oncology Reports
  17. 11β-Hydroxysteroid Dehydrogenase Type 1 and the Metabolic Syndrome
    D. Cidalia, Maria J., Isabel Azevedo, Rosário Monteiro · 2011 · InTech eBooks
  18. Glucocorticoid antagonists and 11β-HSD1 inhibitors
    Minghan Wang · 2007 · Drug Discovery Today Therapeutic Strategies
  19. Rodents as genetic models of obesity
    Yumi Imai, Rexford S. Ahima · 2005 · Drug Discovery Today Disease Models
  20. 11β-Hydroxysteroid dehydrogenase type 1, a target for development of oral antidiabetic drugs (Review)
    Victoria V. Lipson, Maria G. Shirobokova, O. N. Petrova · 2013 · Pharmaceutical Chemistry Journal
  21. Effects of menopause on hepatic 11β-hydroxysteroid dehydrogenase type 1 activity and adrenal sensitivity to adrenocorticotropin in healthy non-obese women
    Shengxian Li, Wei Liu, Lihua Wang, Rong Huang, Qi Chen, Yi‐Hua Wu, Yiting Cai · 2011 · Gynecological Endocrinology
  22. Diazepane–acetamide derivatives as selective 11β-hydroxysteroid dehydrogenase type 1 inhibitors
    Alex Odermatt · 2009 · Expert Opinion on Therapeutic Patents
  23. Local metabolism of glucocorticoids in Prague hereditary hypertriglyceridemic rats – Effect of hypertriglyceridemia and gender
    Petra Klusoňová, Lenka Pátková, Peter Ergang, Ivan Mikšı́k, Josef Zicha, Jaroslav Kuneš, Jiřı́ Pácha · 2011 · Steroids
  24. Cortisol Metabolism as a Regulator of the Tissue-Specific Glucocorticoid Action
    Emilia Sbardella, Jeremy Tomlinson · 2016 · Springer eBooks
  25. Obesity and Hypertension
    Nikheel S. Kolatkar, Abraham Thomas, Gordon H. Williams · 2006 · Fundamental and clinical cardiology
  26. Correction of Insulin Resistance and the Metabolic Syndrome
    Dirk Müller‐Wieland, Jörg Kotzka · 2005 · Handbook of experimental pharmacology
  27. 11β-hydroxysteroid dehydrogenase type 1 : a new therapeutic target post-myocardial infarction?
    Sara J. McSweeney · 2010 · ERA
  28. Obesity, Diabetes, and Hypertension
    Anjanette S. Tan, Stephen Brietzke, David W. Gardner, James R. Sowers · 2006 · Humana Press eBooks
  29. High-carbohydrate diet-induced central obesity in gerbils: 20-hydroxyecdysone effects on adrenal zona fasciculata histology
    Zineb Bellahreche, Ouahiba Sihali-Beloui, Nesrine Semiane, Aicha Mallek, Y. Dahmani · 2025 · Nutrition Clinique et Métabolisme
  30. Shift from visceral to subcutaneous adipose tissue in Cyp17a1-knockout rats prevents the progression of metabolic syndrome
    Beom-Jin Jeon, Jeong‐Hwa Lee, Dong-Hyeok Kwon, Hee-Kyoung Kim, Goo Jang · 2025 · PLoS ONE
  31. Glucocorticoid Receptor Signaling: Multilevel Organization, Roles in Fetal Development, and Postnatal Outcomes
    Sofiya Potapova, Yan Isakov, Ekaterina I. Tyulkova, Oleg V. Vetrovoy · 2026 · International Journal of Molecular Sciences
  32. Advances in 11-HSD1 Inhibitor Development for Addressing Insulin Resistance and Beta-Cell Dysfunction in Type 2 diabetes mellitus
    Pallavi Joshi, Avijit Mazumder, Bhavani Pentela, Abhijit Debnath · 2026 · Journal of Pharmaceutical Innovation
  33. Influencing energy expenditure and substrate utilisation
    John C. Clapham, Jonathan R.S. Arch · 2008 · Birkhäuser Basel eBooks
  34. Salivary Cortisol Can Reflect Adiposity and Insulin Sensitivity in Type 2 Diabetes
    Yoko Matsuzawa, Kenichi Sakurai, Jun Saito, Masao Omura, Tetsuo Nishikaw · 2011 · InTech eBooks
  35. Targeting 11β-hydroxysteroid dehydrogenase type 1 in brain: therapy for cognitive aging?
    Joyce L.W. Yau, Alasdair M. J. MacLullich, Jonathan R. Seckl · 2006 · Expert Review of Endocrinology & Metabolism
  36. Determination of 2-(3-Benzoyl)-4-Hydroxy-1,1-Dioxo-2H-1,2-Benzothiazine-2-yl-1-Phenylethanone by Liquid Chromatography–Tandem Mass Spectrometry
    Zhi Zheng, Jin Sook Song, Byung Hoi Lee, Sung‐Hoon Ahn, Jin Hee Ahn, Jaechun Woo, Ji Young Park, Dae Seok Yoo, Myung Ae Bae · 2013 · Journal of Chromatographic Science
  37. 1-Adamantylamidoxime
    Benjamín Diethelm‐Varela, Carlos F. Lagos, Gonzalo Recabarren‐Gajardo · 2018 · Molbank
  38. Employing Molecular Docking Calculations for the Design of Alkyl (2-Alcoxy-2-Hydroxypropanoyl)-L-Tryptophanate Derivatives as Potential Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1)
    Diego Quiroga · 2023 · Reactions
  39. Corticosteroid Receptors, Their Chaperones and Cochaperones: How Do They Modulate Adipogenesis?
    Judith Toneatto, Nancy L. Charó, Agostina Naselli, Melina Muñoz-Bernart, Antonella Lombardi, Graciela Piwien‐Pilipuk · 2014 · Nuclear Receptor Research
  40. Obesity and Stress: The Melanocortin Connection
    Sara Singhal, Jennifer Wootton Hill · 2018 · Springer eBooks
  41. Endocrine Aspects of the Metabolic Syndrome
    Richard I. G. Holt, Peter H. Sönksen · 2011
  42. 11β-Hydroxysteroid Dehydrogenase Type 1 and Obesity
    Roland H. Stimson, Brian Robert Walker · 2007 · Humana Press eBooks
  43. High Capacity Homogeneous Non-Radioactive Cortisol Detection Assays for Human 11 β -Hydroxysteroid Dehydrogenase Type 1
    Violeta L. Yu, Yanyan Tudor, Clarence Hale, Matthew Plant, Ki Won Kim, Minghan Wang, Yen Nguyen, Tisha San Miguel, Michelle Chen, Rebecca E. Nybo et al. · 2007 · Assay and Drug Development Technologies
  44. Adipose tissue as an active organ: blood flow regulation and tissue- specific glucocorticoid metabolism
    Jonas S. O. Andersson · 2011 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
  45. The Relationship Between Elevations in Glucocorticoids and Diabetes Development in Rats on Skeletal Muscle Insulin Resistance and the Microvasculature
    Emily C. Dunford · 2016 · YorkSpace (York University)
  46. Brain function and glucocorticoids in obesity and type 2 diabetes including effects of lifestyle interventions
    Andreas Stomby · 2015 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
  47. Akr1d1-/- mice have a sexually dimorphic metabolic phenotype with reduced fat mass, increased insulin sensitivity and hypertriglyceridemia in males
    Laura Gathercole, Nikolaos Nikolaou, Anastasia Arvaniti, Shelley Harris, Toryn M. Poolman, Jonathan Hazlehurst, Denise V. Kratschmar, Marijana Todorčević, Ahmad Moolla, Niall J. Dempster et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  48. Obesity
    Undurti Narasimha Das · 2010
  49. The regulation of preadipocyte differentiation by glucocorticoids
    Julianna J. Tomlinson · 2007 · uO Research (University of Ottawa)
  50. Convergence of Multiple Nuclear Receptor Signaling
    Stephanie J. Webb, Keith Cameron Falkner, Thomas E. Geoghegan, Russell A. Prough · 2010 · Elsevier eBooks
  51. Estrogen and Glucocorticoid Metabolism
    Therése Andersson · 2010 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
  52. Regulation and function of 11β-hydroxysteroid dehydrogenase (11β-HSD1) in pancreatic β-cells
    Xiaoxia Liu · 2011 · ERA
  53. Análisis de polimorfismos de genes asociados al síndrome metabólico en niños obesos
    Josune Olza · 2011 · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
  54. Adipose Tissue Hypoxia in Regulation of Angiogenesis and Obesity
    Zoi Michailidou, Jonathan R. Seckl · 2013 · Springer eBooks
  55. TRANSLATIONAL MEDICINE AND ITS IMPACT ON DIABETES DRUG DEVELOPMENT
    Roberto A. Calle, Ann E. Taylor · 2011 · Cambridge University Press eBooks
  56. Modelling altered Glucocorticoid Sensitivity: From HPA axis to metabolic abnormalities in mice and humans
    Zoi Michailidou · 2008 · ERA
  57. 11β‐Hydroxysteroid Dehydrogenase Type 1 as a Therapeutic Target for Type 2 Diabetes
    Clarence Hale, David J. St. Jean · 2011
  58. Adipose tissue inflammation, hepatic fat accumulation and insulin resistance
    Maria Kolak · 2008 · Figshare
  59. Synthesis and biological evaluation of α-sulfonamido-N-adamantanecarboxamide derivatives as 11β-HSD1 inhibitors
    Young‐Hoon Kim, Seung Kyu Kang, Gwi Bin Lee, Kyu Myung Lee, Ashok Kumar Jaladi, Ki Young Kim, Sang Dal Rhee, Jeongmin Joo, Myung Ae Bae, Won Koo Lee et al. · 2015 · MedChemComm
  60. On-column ligand exchange for structure-based drug design: a case study with human 11β-hydroxysteroid dehydrogenase type 1
    Wenying Qin, Russell A. Judge, Kenton L. Longenecker, Larry R. Solomon, John E. Harlan · 2012 · Acta Crystallographica Section F Structural Biology and Crystallization Communications
  61. Spontaneous rupture of adrenal incidentaloma in a patient with subclinical Cushing’s syndrome, whose clinical expression is metabolic syndrome
    Yasumitsu Takahi, Sachiko Tamba, Yosuke Sekii, Akihito Kamoto, Toshiaki Yoshioka, Hiroshi Yamamoto, Mitsuaki Kyo, Yoshinari Obata, Kenji Saisho, Koji Yamamoto et al. · 2014 · Diabetology International
  62. Laboratorial Diagnosis of Cushing’s Syndrome: Differential Diagnosis with Pseudo Cushing’s Conditions as Obesity, Alcoholism and Depression
    Martina De Martin, Francesca Pecori Giraldi, Francesco Cavagnini · 2010 · Humana Press eBooks
  63. 11β-Hydroxysteroid Dehydrogenase Type 1 is not Overexpressed in Cushing’s Syndrome Adipose Depots
    Claudio Elias Kater · 2014 · Journal of Diabetes Metabolic Disorders & Control
  64. Efeitos da atorvastatina sobre a inflamação e resistência à insulina em camundongos obesos.
    Daniela Tomie Furuya · 2008
  65. Insulin Resistance, Dyslipidemia, Type 2 Diabetes Mellitus and Metabolic Syndrome
    Undurti Narasimha Das · 2011 · Springer eBooks
  66. Novel pharmaceutical approaches to regulate glucose homeostasis
    Magnus Sundbom · 2010 · Open Archive (Karolinska Institutet)
  67. Association/National Heart, Lung, and Blood Institute Scientific Statement Diagnosis and Management of the Metabolic Syndrome: An American Heart
    Cassidy S. Smith, John A. Spertus, Barry A. Franklin, David J. Gordon, Ronald M. Krauss, Peter J. Savage, Scott M. Grundy, James I. Cleeman, Stephen R. Daniels, Karen A. Donato · 2006
  68. Interactions between glucocorticoid metabolism and inflammation in obesity and insulin resistance.
    Mark Nixon · 2011 · ERA
  69. TheMotherortheFetus?11-HydroxysteroidDehydrogenase Type2NullMiceProvideEvidenceforDirectFetal ProgrammingofBehaviorbyEndogenousGlucocorticoids
    MeganC . Holmes · 2006
  70. PARTICIPAÇÃO DO CANAL DE POTÁSSIO DEPENDENTE DE ATP (KATP) NA RESISTÊNCIA À INSULINA EM MÚSCULO ESQUELÉTICO: CORRELAÇÃO COM O GENE DO GLUT4
    Fisiologia Humana · 2013
  71. Adrenal Function and Obesity
    Laura Proietti-Pannunzi, Cecilia Motta, Vincenzo Toscano · 2014 · Springer eBooks
  72. Biochemical and molecular targets of novel antidiabetic agents
    Amar Bahadur Singh · 2009 · INFLIBNET
  73. Genetically Diabetic Animals
    Günter A. Müller · 2015 · Springer eBooks
  74. and onset of obesity
    Claude Roberge, André C. Carpentier, Marie‐France Langlois, Jean‐Patrice Baillargeon, Jean‐Luc Ardilouze, Nicole Gallo‐Payet · 2007
  75. Title of dissertation: HIGH SUCROSE, FRUCTOSE, AND GLUCOSE DIETS AND GLUCOCORTICOID DYSREGULATION IN
    Edra London, Thomas W. Castonguay · 2009
  76. Katedra i Klinika ChorÛb Metabolicznych, Collegium Medicum Uniwersytetu Jagielloæskiego w Krakowie 2Zak‡ad Biochemii Klinicznej Katedry Biochemii Klinicznej, Collegium Medicum Uniwersytetu Jagielloæskiego w Krakowie
    Magdalena Szopa · 2007
  77. The impact of glucocorticoids upon the insulin sensitivity of skeletal muscle
    Stuart Morgan · 2010 · University of Birmingham Institutional Research Archive (University of Birmingham)
  78. Generation of Adipose Tissue-Specific Transgenic Mouse Models
    Xian‐Cheng Jiang · 2008 · Methods in molecular biology
  79. 9. A Novel, Interdisciplinary Approach Toward the Rapid Expansion of Obesity and Metabolic Syndrome in Japan.
    Hiroaki Masuzaki · 2011 · Nihon Naika Gakkai Zasshi
  80. Influence of sub-chronic selective 11β-hydroxysteroid dehydrogenase 1 inhibition on the hypothalamic-pituitary-adrenal axis in female cynomolgus monkeys
    Bradford S. Hamilton, Corinna Schoelch, Annette Schuler‐Metz, Paula M. Krosky, Deepak S. Lala, David A. Claremon, Gerard M. McGeehan · 2016 · European Journal of Pharmacology
  81. Glucocorticoids as Modulators of Adipose Inflammation
    Nicholas M. Morton · 2009 · Oxidative stress and disease
  82. 71 Obese Mouse Models
    Deborah J. Good · 2008
  83. AVALIAÇÃO DO EFEITO DA OBESIDADE NA ASSOCIAÇÃO ENTRE DOENÇA CARDÍACA ISQUÊMICA E DISFUNÇÃO ERÉTIL.
    Programa De Pós-Graduação, Ciências Médicas · 2010
  84. 5. 酵素，11β-HSD 1を介した肥満及び糖・脂質代謝異常への介入―脂肪組織機能異常に対する治療介入の意義と展望―
    益崎裕章, 植田 玲, 充生 島袋 · 2011 · 糖尿病
  85. Adverse developmental programming of the adult phenotype by fetal glucocorticoid excess and its prevention by postnatal dietary Omega-3 fatty acids
    Caitlin S. Wyrwoll · 2006 · UWA Profiles and Research Repository (UWA)
  86. Current literature in diabetes
    2004 · Diabetes/Metabolism Research and Reviews
  87. Obesity
    Undurti Narasimha Das · 2011 · Springer eBooks
  88. Viewpoint 1
    Ralf Paus, Johannes Christian Klein, Mathias Faßhauer · 2006 · Experimental Dermatology
  89. Genetically Diabetic Animals
    Günter A. Müller · 2015 · Springer eBooks
  90. Shift from visceral to subcutaneous fat in Cyp17a1 knockout rats prevent the progression of metabolic syndrome
    Beom-Jin Jeon, Jeong‐Hwa Lee, Dong-Hyeok Kwon, Hee-Kyoung Kim, Goo Jang · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  91. Are Southeast Asians cushingoid? A molecular explanation for the high incidence of metabolic syndrome
    Undurti Narasimha Das · 2024 · Elsevier eBooks
  92. Obesity in childhood and adolescence: epidemiology, management and mechanisms
    Amanda Jane Drake · 2006 · The Journal of the Royal College of Physicians of Edinburgh
  93. Glucocorticoid metabolism and activation
    Nantia Othonos, Jeremy Tomlinson · 2025 · Elsevier eBooks
  94. Adipocyte-specific modulation of 11β-HSD enzymes for the treatment of obesity in male mice
    Merc Emil Matienzo, Junhyeong Lee, Sangyi Lim, Edzel Evallo, Chang‐Min Lee, Keon Kim, Min-Jung Park, Dong‐Il Kim · 2025 · American Journal of Physiology-Cell Physiology
  95. Structure-based design, synthesis, and evaluation of tetrahydrotriazolothiazepine derivatives as novel 11β-hydroxysteroid dehydrogenase type 1 inhibitors
    Yukinobu Numata, Toru Hasegawa, Makoto Mori, Tsuyoshi Shinozuka, Yuko Yamamoto, Masatoshi Honzumi, Chinami Kanayama, Atsushi Aoyagi, Manabu Abe, Yuka Ofune et al. · 2025 · Bioorganic & Medicinal Chemistry
  96. Novel nonsteroidal inhibitors of the human 11-beta hydroxysteroid dehydrogenase type 1 enzyme for the treatment of obesity and metabolic syndrome
    Pablo A. González, Cristián A. Carvajal, Alejandra Tapia-Castillo, Gonzalo Recabarren, Benjamín Diethelm‐Varela, Eduardo Riquelme, Mauricio A. García, Andrea Vecchiola, Fidel A. Allende, Jorge A Pérez et al. · 2025 · Research Square
  97. Model-informed prediction of human pharmacokinetics and first-in-human dose selection of J2H-1702, a novel 11β-hydroxysteroid dehydrogenase type 1 inhibitor for metabolic-associated steatohepatitis
    Inkyu Kim, Inyoung Hwang, Sang Won Lee, Yun Kim · 2026 · European Journal of Pharmaceutical Sciences
  98. Random forest-based QSAR and molecular dynamics insights into steroidal pregnanes as 11β-hydroxysteroid dehydrogenase type 1 modulators for type 2 diabetes
    Oludare Michael Ogunyemi, Gideon Ampoma Gyebi, Oladimeji S. Macaulay, Babatunde A Olabuntu, Charles O. Olaiya, Saheed Sabiu · 2026 · Computational Biology and Chemistry
  99. Perturbations du métabolisme glucidique et azoté dans des modèles d'obésité induite par le régime hyperlipidique ou par les glucocorticoïdes
    Thi Thu Huong Do · 2016 · theses.fr (ABES)
  100. Impact of CBG deficiency on emotional and cognitive processes
    Gabriela Ferreira de Medeiros · 2016